Shilpa Medicare is currently trading at Rs. 661.00, up by 15.40 points or 2.39% from its previous closing of Rs. 645.60 on the BSE.
The scrip opened at Rs. 648.00 and has touched a high and low of Rs. 673.90 and Rs. 637.65 respectively. So far 7509 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 786.75 on 21-Dec-2016 and a 52 week low of Rs. 517.35 on 29-Sep-2016.
Last one week high and low of the scrip stood at Rs. 689.30 and Rs. 636.95 respectively. The current market cap of the company is Rs. 5225.48 crore.
The promoters holding in the company stood at 54.74%, while Institutions and Non-Institutions held 31.89% and 13.37% respectively.
Shilpa Medicare has successfully completed inspection carried out by the United States Food and Drug Administration (USFDA) at its formulations manufacturing facility (SEZ unit) located at Jadcherla, Telangana, India with one minor observation. The inspection was carried out between July 24 and July 28, 2017.
The company is in the process of submission of corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines in response to the form 483 issued at the end of inspection.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1529.60 |
Dr. Reddys Lab | 5827.50 |
Cipla | 1402.10 |
Zydus Lifesciences | 1104.45 |
Lupin | 1655.05 |
View more.. |